Moderna CEO Stéphane Bancel deflected concerns about the new presidential administration's potential impact on life sciences ...

As Bakey opens it fourth and newest location, the renowned Boston bakery plans to stay devoted to churning out fresh pastries ...

The new cafe-rotisserie near Lechmere specializes in well-seasoned dishes with Mediterranean and Middle Eastern flavors.

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...

Job cuts in Cambridge and Plainville are the second workforce reduction planned for the facilities in the past three months.

It's the second time in less than three months that the Waltham-based life sciences firm has announced layoffs.

Whether it’s Chinese or Japanese or vegan diner food you’re after, you can find it in this Cambridge neighborhood. Narrowing Central Square’s drinking and dining scene down to just 15 must-try spots ...

Moderna (NASDAQ:MRNA) traded lower in the premarket on Wednesday after Goldman Sachs downgraded the COVID-19 vaccine maker to Neutral from Buy, citing a lack of clarity over its revenue outlook.

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for priority review a supplemental new drug application ...

Merck is investigating WELIREG in rare oncologic diseases, RCC and other tumor types through a broad clinical development program, including in Phase 2 and 3 trials evaluating WELIREG as monotherapy ...

Frazier, whose extended tenure as Merck CEO will have past the 10-year milestone when he steps down on 30 June, said the results were "solid" given the high proportion of physician-administered ...

Following four straight sessions of gains, Moderna (NASDAQ:MRNA) shares continued to trade higher in the premarket on Friday after the company received a tender to supply its COVID-19 vaccine in the ...